fda warning letters glp-1 compounded september 2025 U.S. sends drug advertising to Lilly, Novo, Hims FDA issued 25 warning letters

It also alleviated muscle damage in resistance trained and untrained groups (56) , muscle wasting in patients with pemphigus vulgaris (61) , and prevented cardiovascular disease in hemodialysis patients (24)

Retatrutide: 90% liver fat normalization in 48 weeks Retatrutide, a novel triple GIP/GLP-1/glucagon receptor agonist, produced extraordinary results in patients with obesity and MASLD

As of December 2025, there is a centralized litigation for people alleging vision loss caused by Wegovy and other GLP-1 drugs

Glucagon is another hormone that is produced by the pancreas

Beyond pigmentation, it influences the melanocortin system in the brain, modulating appetite, libido, and energy balance